politics Archives

The Pharmalot View By Ed Silverman

Oh, the irony! Trump may like to vilify drug makers, but now he needs them more than ever

Politics By Lev Facher

Q&A: Vivek Murthy, a top Biden adviser, on Covid-19 vaccines, the drug industry, and the future of public health

Politics By Lev Facher

A Senate race in Kansas between two doctors sets the stage for an election hyper-focused on health policy — and on Covid-19

Special Report By Lev Facher

Pharma is showering Congress with cash, even as drug makers race to fight the coronavirus

Politics By Lev Facher

Elbow bumps, social distancing, and Medicare for All: The coronavirus pandemic dominated every aspect of the Democratic debate

Politics By Andrew Joseph

In their words: Warren, Buttigieg, Klobuchar, and other Democrats explain exactly how they’d lower drug prices

Politics By Nicholas Florko

More than a dozen Democrats are bringing people with sky-high insulin bills to the State of the Union

Politics By Lev Facher

House Republicans fuel Capitol Hill chaos with competing drug pricing bill

Pharmalot By Ed Silverman

Pharmalittle: Purdue bankruptcy sets tone for opioid cases; Sanders criticizes Biden for praising pharma

Pharma By Priyanka Dayal McCluskey — Boston Globe

WHO rescinds opioid guidelines following criticism by two U.S. lawmakers

Politics By Nicholas Florko

How do you improve Medicare? Maybe you watch Major League Baseball

The Pharmalot View By Ed Silverman

Tweet this: Gottlieb’s leaving, and so is FDA’s highly effective communicator

Politics By Rick Berke

A letter from Executive Editor Rick Berke: All eyes on today’s drug pricing hearing

Politics By Nicholas Florko

Defending the middlemen: JC Scott on testifying before Congress, challenging Trump, and revamping PBMs’ image

Heavyweights By Rick Berke

Billionaire Sean Parker calls China’s gene-edited babies ‘Sputnik 2.0,’ praises FDA, and offers career advice for millennials

Biotech By Damian Garde, Rebecca Robbins and Adam Feuerstein

A tweet from Alexandria Ocasio-Cortez prompts a deeper debate over how drugs are made

Pharmalot By Ed Silverman

Sanders accuses a drug maker of ‘immoral exploitation’ for the price of a rare disease drug

Pharmalot By Ed Silverman

Here’s how Massachusetts officials hope to lower their Medicaid drug spending

Politics By Robert Weisman — Boston Globe

Drug costs plague seniors, but legislative relief may be elusive

Politics By Lev Facher

3 state legislative battles to watch in 2019

Pharmalot By Ed Silverman

Big drug makers are socking away more cash lately thanks to the tax overhaul, and it’s likely to be used for more deals

Donald Trump speaks prior to signing bills intended to lower prescription drug prices

Politics By Nicholas Florko

Trump will give speech on drug prices Thursday

Pharmalot By Ed Silverman

New U.S. trade deal with Canada and Mexico is criticized for provisions affecting drug prices

Pharmalot By Elizabeth Cooney

Pharmalittle: Markups on generics are growing; drug-pricing rhetoric heats up

Politics By Lev Facher

Most Read

Trump urges people to avoid discretionary travel and limit gatherings to fewer than 10 people

‘Reject Big Pharma’: Anti-vaccine activists co-opt a populist slogan to try to repeal a state immunization law

Trump taps Pence to lead U.S. coronavirus response

As medical professionals, my husband and I know the Nigerian travel ban is cruel. Now the pain is personal

VA declines broad coverage for new J&J depression drug touted by Trump

A new push aims to bring mental health and addiction into the 2020 campaign conversation

These Republicans campaigned on a bold drug-pricing pledge. Since they won, they’ve gone silent

Webinar: Is the new Congress ready to lower drug costs?

All Coverage

Oh, the irony! Trump may like to vilify drug makers, but now he needs them more than ever

Q&A: Vivek Murthy, a top Biden adviser, on Covid-19 vaccines, the drug industry, and the future of public health

A Senate race in Kansas between two doctors sets the stage for an election hyper-focused on health policy — and on Covid-19

Pharma is showering Congress with cash, even as drug makers race to fight the coronavirus

Elbow bumps, social distancing, and Medicare for All: The coronavirus pandemic dominated every aspect of the Democratic debate

In their words: Warren, Buttigieg, Klobuchar, and other Democrats explain exactly how they’d lower drug prices

More than a dozen Democrats are bringing people with sky-high insulin bills to the State of the Union

House Republicans fuel Capitol Hill chaos with competing drug pricing bill

Pharmalittle: Purdue bankruptcy sets tone for opioid cases; Sanders criticizes Biden for praising pharma

WHO rescinds opioid guidelines following criticism by two U.S. lawmakers

How do you improve Medicare? Maybe you watch Major League Baseball

Tweet this: Gottlieb’s leaving, and so is FDA’s highly effective communicator

A letter from Executive Editor Rick Berke: All eyes on today’s drug pricing hearing

Defending the middlemen: JC Scott on testifying before Congress, challenging Trump, and revamping PBMs’ image

Billionaire Sean Parker calls China’s gene-edited babies ‘Sputnik 2.0,’ praises FDA, and offers career advice for millennials

A tweet from Alexandria Ocasio-Cortez prompts a deeper debate over how drugs are made

Sanders accuses a drug maker of ‘immoral exploitation’ for the price of a rare disease drug

Here’s how Massachusetts officials hope to lower their Medicaid drug spending

Drug costs plague seniors, but legislative relief may be elusive

3 state legislative battles to watch in 2019

Big drug makers are socking away more cash lately thanks to the tax overhaul, and it’s likely to be used for more deals

Trump will give speech on drug prices Thursday

New U.S. trade deal with Canada and Mexico is criticized for provisions affecting drug prices

Pharmalittle: Markups on generics are growing; drug-pricing rhetoric heats up

Is mistrust of ‘big pharma’ enough to help unseat a Democratic stalwart in Congress?